- Home
- Our Company
- Suppliers
Suppliers
Just as we believe that good health is the foundation of vibrant lives, thriving communities and forward progress, at Johnson & Johnson we also pride ourselves on fostering healthy supplier relationships that are built on trust, transparency and unparalleled innovation, quality and reliability.
Working with our valued partners, we uphold the highest standards for responsible sourcing and corporate citizenship, encouraging our suppliers to embrace new technologies, source innovative solutions and deliver new business models that contribute to our mutual objectives for growth, sustainability and streamlined processes.
Expand
Collapse
Featured stories
How Johnson & Johnson is helping people displaced by war and conflict restart their lives
A Partnership for Good program expands the company’s talent pool in Europe while assisting the mental and financial health of people displaced by conflict. Here’s how this novel initiative helped one young Ukraine War refugee get a foothold.
Turning our supplier spend into societal good
Johnson & Johnson’s Global Supplier Diversity & Inclusion team is stepping up spending with social enterprises around the world to deepen its impact in local communities.
Securing the future of surgery, one staple at a time
Faced with the challenge of improving stapling performance for consistent outcomes in challenging tissue, Ethicon drew inspiration from its broad and talented supplier base.
At Johnson & Johnson, our goal is to collaborate with our 38,500 suppliers around the world and use our collective ingenuity to change the trajectory of health for humanity.
Shashi Mandapaty
Chief Procurement Officer, Johnson & Johnson
More from Johnson & Johnson
This scientist couldn’t save his father from lung cancer—but the targeted treatments Robert Zhao, Ph.D., has since developed have helped countless others
Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.
After their husbands were diagnosed with multiple myeloma, these 3 care partners became health equity activists
Kimberly Alexander, Michelle Ware-Ivy and Marsha Calloway-Campbell learned firsthand that Black individuals develop multiple myeloma at higher rates. That’s why they joined Johnson & Johnson’s That’s My Word® health equity campaign, which builds awareness about the disparities surrounding this rare blood cancer.
How Johnson & Johnson is working to get medications to people around the world who need them most
In the just-released 2024 Access to Medicine Index, the company ranks among the top 5 improving access to medicines.